In situ and quantitative measurements of adenosine 5′-triphosphate
(ATP) in single living cells are highly desired for understanding
several sorts of necessary physiological and pathological processes.
Due to its small size and high sensitivity, an ultra-microelectrode
can be used for single-cell analysis. However, ATP is difficult to
detect in single cells because it is nonelectroactive and low in content.
Herein, we introduced an electrochemical nano-biosensor based on an
amphiphilic aptamer-assisted carbon fiber nanoelectrode (aptCFNE)
with high signal-to-noise ratio. The low current (e.g., 60 pA) and
the tiny diameter of the tip (ca. 400 nm) of the nanosensor made it
noninvasive to living cells. The amphiphilic aptamer has good biocompatibility
and can be stably modified to the surface of functionalized electrodes.
CFNE, which was modified with ferrocene-labeled aptamer, could quickly
and selectively detect ATP content in the nucleus, cytoplasm, and
extracellular space of single HeLa cells. The results showed that
the ATP contents in the nucleus, cytoplasm, and extracellular space
were 568 ± 9, 461 ± 20, and 312 ± 4 μM, respectively.
The anticancer drug treatment effects on the cellular level were further
recorded, which was of great significance for understanding ATP-related
biological processes and drug screenings. This strategy is universally
applicable to detect other targets by changing the aptamer sequence,
which will greatly improve our understanding of cell heterogeneity
and provide a more reliable scientific basis for exploring major diseases
at the single-cell level.